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ABSTRACT OF DISSERTATION

FACTORS ASSOCIATED WITH TASTE PERCEPTION AND DIETARY
CONSUMPTION PATTERNS IN INDIVIDUALS WITH OR AT-RISK FOR
CARDIOVASCULAR DISEASE
Excessive intake of sodium, sugar, fats, and other unhealthy dietary patterns
significantly contribute to cardiovascular disease (CVD) risk and, among those with
diagnosed CVD, to deleterious outcomes. Taste perception is one of the most important
factors influencing dietary intake and there are many factors that can alter it such as
medication and genetic variations. Yet there has been relatively little research on
influences of taste perception on self-management of CVD and CVD risk.
The purpose of this dissertation is to examine the association of various factors
and taste perception in order to add to our understanding of what may or may not
influence dietary consumption behaviors among persons at-risk for or with diagnosed
CVD. The specific aims of this dissertation were to 1) examine the association between
dietary sodium consumption and antihypertensive medication regimen in patients with
heart failure (HF); 2) examine the associations between variants of the TAS2R38
haplotype and dietary intake patterns of salt, sugar, fat, alcohol and vegetables in
community dwelling adults in Appalachia Kentucky with 2 or more CVD risk factors;
and 3) examine associations between the TAS2R38 haplotype and salt taste sensitivity and
sodium consumption in patients with HF and their family caregivers.
Specific aim one was addressed by evaluating whether prescribed diuretic, beta
blocker, angiotensin II receptor blockers (ARBs), and angiotensin converting enzyme
(ACE) inhibitors predicted sodium consumption as evidenced by sodium density in a
sample of patients with HF when controlling for age, gender, ethnicity, smoking status,
New York Heart Association (NYHA) class and body mass index (BMI). The results of
this study indicate that, among patients with HF, prescribed ACE inhibitor is predictive
of higher sodium consumption but not prescribed diuretics, beta blockers and angiotensin
receptor blockers. To address specific aim two, a secondary analysis of data of a sample

of adults living in rural Appalachia with 2 or more CVD risk factors was conducted. We
examined if having one or two PAV haplotypes was predictive of patterns of salt, sugar,
fat, alcohol and vegetable consumption, controlling for age, gender, smoking status, BMI,
and prescribed ACE and ARB. There were no associations between TAS2R38 haplotype
and any of these dietary intake patterns. Specific aim three was addressed in a study to
examine the associations between the TAS2R38 haplotype and salt taste sensitivity and
sodium consumption as indicated by 24-hour urinary sodium excretion in patients with
HF and their family caregivers, controlling for age, gender, ethnicity, smoking status, and
fungiform papillae number. Our outcomes indicated that haplotype did not predict salt
taste sensitivity but did predict 24-hour urinary sodium excretion, with significantly less
levels of urinary sodium excretion among participants who were homozygous for the
PAV haplotype compared to those who were heterozygous for the PAV haplotype or
homozygous for the AVI haplotype. The results of these studies, separately and in
concert, provide greater understanding of influences of taste perception on selfmanagement among people who are at-risk for or who have diagnosed CVD.
KEYWORDS: Taste perception, dietary patterns, salt taste perception, cardiovascular
disease, genetics
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CHAPTER ONE:
Introduction
In the United States, the average daily sodium consumption in the general
population is much higher than the daily recommended amount. Nearly 90% of adults
have a dietary intake that exceeds the recommended guideline of less than 2,300 mg a
day,1-3 with the majority consuming more than 3500 mg a day.1,4,5 This is of particular
importance when one considers that high dietary sodium consumption has been linked to
hypertension, while reducing sodium intake can lower blood pressure.6,7 Excess sodium
intake has also been associated with higher risk of stroke and cardiovascular disease.7,8
Addressing dietary sodium intake is of particular concern for individuals already
living with cardiovascular disease (CVD) such as heart failure (HF). Annually, over
870,000 people in the U.S. are newly diagnosed with heart failure (HF) and more than 5.8
million Americans are currently living with HF.9,10 Heart failure carries a significant
burden of morbidity and mortality with 50% likelihood of death within 5 years of initial
diagnosis. It also results in an estimated $30.7 billion annually in health care
expenditures,10 a substantial portion of which is due to HF re-hospitalizations.11 Fluid
overload due to excessive sodium intake is a major cause of HF exacerbation resulting in
re-hospitalization.12
The linkages between overconsumption of sodium and risk for CVD as well as
exacerbation of existing conditions such as HF underscore the importance of
interventions directed toward decreasing dietary sodium consumption. Yet sodium
reduction has proven to be difficult. To more effectively intervene to reduce dietary
sodium intake requires understanding of mechanisms associated with sodium
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consumption. There are many important determinations of salt consumption such as
culture,13 cost, and convenience.14 Among the most important influences, however, is
taste.14,15
Taste perception and dietary consumption
Taste perception occurs when chemical particles from our food are received by
the taste receptor cells on our tongue, setting off chemical and neural processes that result
in identification and appraisal of the stimulus.15 Taste receptor cells are located in taste
buds, called papillae on the tongue. There are three types of papillae: circumvillae
papillae on the posterior aspect of the tongue, folate papillae on the lateral sides of the
tongue, and fungiform papillae on the anterior portion of the tongue.16 There are four
types of taste cells: I, II, III, and basal.16,17 Types I-III are open to the oral cavity and
interact directly with tastants, or taste-provoking chemicals, through binding with taste
receptor proteins. Most of these are G protein-coupled receptors (GPCR).18,19 GPCR cells
are highly sensitive, with one cell activating dozens of different g proteins.20 Of the five
taste modalities, bitter, sweet, and umami all use GPCRs to detect a particular taste.21 Salt
taste, on the other hand, is not as well understood. While the amiloride sensitive epithelial
sodium channel (ENaC) is involved in salt taste, other mechanisms that have a role in salt
taste perception have yet to be identified22 and more research into these mechanisms is
required. As salt taste has been mistaken for bitter,22 bitter taste is a possible mechanism
to explore. Moreover, we know that some forms of bitter taste perception are highly
heritable and passed down genetically in families, indicating the importance of genetics
in determining taste.23
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Bitter taste is detected with a mixture of at least 30 high-affinity GPCRs that
respond to a wide variety of bitter compounds and are called T2Rs, most of which are
located in fungiform papillae.16,20 The development of so many receptors (more than any
other of the taste modalities) is largely protective as bitter taste serves as a warning that a
substance may be toxic to the body. Bitter taste is a deterrent to consumption.18,20 Of
particular interest are the taste receptors coded by the TAS2R38 gene, which are wellknown to denote sensitivity to phenylthiocarbamide (PTC) and 6-n-propylthiouracil
(PROP), two substances that can taste exceptionally bitter depending on genotype.18,24
The TAS2R38 receptors are known to interact selectively with compounds that contain
the N-C=S thiourea group, which results in the bitter taste of both PROP and
PTC.17,25,26It is also known that substances that are chemically related to PROP and PTC
but do not contain this chemical group do not activate the TAS2R38 receptors.25 Neither
PROP nor PTC appear naturally in foods, however glucosinolates are chemically similar
to PROP and PTC and naturally occur in some bitter tasting vegetables such as broccoli,
cabbage, and brussels sprouts. These vegetables activate this receptor.23-25,27
TAS2R38 gene and salt taste
Ability to taste these chemicals has been linked to the haplotype inherited on the
TAS2R38 gene. There are two common haplotypes associated with bitter taste status:
PAV and AVI. These haplotypes occur from base pair substitutions at three different
single nucleotide polymorphisms (SNPs) locations, which alter the protein synthesized:
proline versus alanine at position 49 (rs713598), alanine versus valine at position 262
(rs1726866), and valine versus isoleucine at position 296 (rs1024639).18,23,26,28,29 These
SNPs occur in strong linkage disequilibrium with each other.23,26
3

PROP supertasters are known to be highly sensitive to select bitter chemicals; it
has also been proposed that sensitivity to PROP bitterness may also correlate with
heightened taste sensitivity in the other taste modalities (salty, sweet, and sour). The
relationship between salt and bitter taste was proposed by Bartoshuk et al. in their article
published in 1998,30 which debunked the notion that salt taste intensity was a good
control measure to compare with bitterness intensity. In this study, the authors found that
PROP super tasters tended to rate salt taste as more intense than those who were medium
tasters and nontasters when samples were giving in as scaling order with PROP presented
last.30 Bajec et al performed an experiment that examined the interaction of thermal taste
status and PROP taste status in the four basic taste modalities. Despite finding no
interaction effects between thermal taste and PROP taster status with taste intensity
ratings across taste modalities; researchers found that supertasters report higher intensity
in salt taste as well as in the other taste modalities.31
Likewise, Hayes et al found that taste intensity ratings were positively correlated
to PROP bitterness taste intensity; individuals that reported greater PROP bitterness also
reported greater saltiness then those who reported PROP bitterness as less bitter.32 These
results indicate that PROP supertasters may experience greater saltiness due to greater
sensitivity to changes in sodium concentration.32 Fischer et al. conducted a study that
examines associations between PROP taste intensity, other taste intensities and TAS2R38
genotype.29 These results confirmed that correlations existed between PROP bitterness
intensity and the intensity of the other taste modalities (salt, sweet, sour, and quinine
bitterness).29 This was particularly evident for PAV homozygotes, who showed a stronger
relationship between PROP and intensity of the 4 basic tastes.29
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Finally, there is some anatomical evidence that links the two taste modalities. In a
recent study that examined taste receptor cells expressed in human derived cell lines,
researchers noted that common genes expressed in these cells were TAS2R38, which
codes for the bitter taste receptor in questions, as well as SCNN1B and SCNN1D.19 The
latter two genes, SCNN1B and SCNN1D, are known to code for the ENaC that are
responsible, in part, for salt taste.19 While this study does not confirm any links between
these two taste modalities, it is interesting to note that the receptors for them are
expressed in the same cells. As these cells are located in fungiform papillae,19 it is
possible that this becomes relevant when one considers that PROP supertasters often have
greater numbers of fungiform papillae. It extends logically that the expression of these
receptors in the same cells may explain in part the relationship between the two taste
modalities and intensity ratings.
Other factors that affect salt taste
While the relationship between TAS2R38 genotype and salt taste intensity has
been explored through research, the relationship between genotype and salt taste
sensitivity has not. Moreover, the relationship of fungiform papillae number, genotype,
salt taste sensitivity, and dietary sodium consumption has not been investigated.
Understanding the links between these variables is crucial, particularly in those patients
who must limit their sodium intake: those with hypertension, heart failure, or other
cardiovascular disease. Further research is necessary to explore these factors in order to
inform the development of dietary interventions to decrease dietary sodium consumption.
Genotype is not the only known factor that affects taste perception. Other factors
such as age, gender, smoking status, prescribed medication, and number of fungiform
5

papillae are all known to be correlated with changes in taste.18,33,34 Two of the most well
researched factors are fungiform papillae number and age.
Fungiform Papillae. As discussed earlier, the sensory equipment that allows us to
taste, namely taste receptors, lie on the tongue and in the oral cavity. While there are
different types of taste buds, the receptors for bitter taste are found predominantly in
fungiform papillae. Number of fungiform papillae, also known as taste bud density, is
known to alter ability to taste across taste modalities. In 1990, Miller et al. conducted an
experiment in university student where participants were divided into high density and
low density taste bud numbers in which the high density group was found to have
significantly higher intensity ratings for sucrose, salt, and PROP bitterness.33,35 It was
later theorized that those who possessed the PAV haplotype anatomically had more
fungiform papillae on the surface of the tongue as well as increased nerve density. This
would increase the intensity of the signal because a greater area is stimulated.31 Evidence
has been contradictory on this point.
There is some evidence that those with the PAV haplotype may have more
fungiform papillae than those with the AVI haplotype however, this occurs independently
of TAS2R38 genotype.18,36 In a more recent study, there were no difference in fungiform
papillae between the different haplotypes.37 That said, Hayes et al. found that PROP
bitterness taste increased in individuals who were homozygous for the AVI haplotype
who also had greater numbers of fungiform papillae and this effect extended to PAV
homozygotes.18
Age. It is well known that taste sensitivity is altered by age though natural
changes in the body. Taste thresholds for food are known to rise as a person ages.38 These
6

thresholds are the amount of a tastant required to sense the taste and identify the flavor; if
the amount needed is low, our taste threshold is considered low. If we require a lot of the
substance, our threshold is high.38 With high thresholds, the normal amount of a tastant,
like salt for example, will not produce the sensation of saltiness that we are used to
tasting and this may render foods tasteless.38 The root in these differences is thought to be
related to changes in the speed of neural signaling and in functional Magnetic Resonance
Imaging (fMRI) studies, lower brain activation is seen in older individuals to bitter
taste.39
In particular, it has been noted that younger individuals are often more sensitive to
the bitter taste of PTC and PROP than older individuals.40 This difference seems to be
more prevalent with PAV/AVI heterozygotes; children with this haplotype have been
shown to be more sensitive to PROP bitterness then either adolescents or adults with the
same haplotype.40 This effect was not seen in either homozygous haplotype.
Gender. Gender may also influence taste sensitivity and intensity. In some
studies, women have shown greater mean PROP intensity ratings than men.29 Hormonal
changes in women have been shown to be correlated with heightened liking and
consumption for salt.32,41 In a recent magnetoencephalography (MEG) study, female
participants showed more high frequency channels than males, which is assumed to mean
that they had better taste response then men.42 In some study populations, there have been
more females with enhanced bitter taste and a corresponding increase in nontasters
among men.43 Finally, PROP taster status has been shown to that TAS2R38 haplotype
was associated with healthy eating habits but only in female participants.44
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Medication. Another key factor, though less well understood, is medication
prescribed to the individual. Medications such as antihypertensive (such as angiotensin
converting enzyme [ACE] inhibitors, beta blockers, and angiotensin II receptor blockers
[ARBs]) and chemotherapy drugs are well known to alter taste sensation and
sensitivity.34 Of particular concern are ACE inhibitors because they are widely prescribed
to patients with hypertension and heart failure, both of which need to limit their sodium
intake. ACE inhibitors are known to alter taste sensitivity both alone and in conjunction
with other medications such as ARBS or beta blockers.34,45 What is not known about
these medications is how the resulting alteration in taste sensitivity effects eating
behavior. In particular, the links between medication and dietary sodium consumption are
not well defined or understood. Appropriate understanding of this association is crucial in
order to appropriately prepare patients on these medications for the additional barrier to
reducing dietary sodium intake.
Purpose of Dissertation and Summary of Subsequent Chapters
The purpose of this dissertation was to examine factors that are associated with
salt taste perception to elucidate possible connection to sodium consumption behavior
among persons with cardiovascular disease and heart failure. The chapters of this
dissertation focus on the factors separately and together.
In Chapter 2, medication was considered for its association with sodium density
in the diet of patients with heart failure. The focus of Chapter 3 was TAS2R38 genotype
and its association with sodium consumption as well as the consumption of other
nutrients among people at-risk for cardiovascular disease. Chapter 4 is a report on
TAS2R38 genotype associations with sodium consumption among patients with HF and
8

their family caregivers, controlling for fungiform papillae number, age, and medication
prescribed.
Little is known regarding the association of anti-hypertensive medication regimen
and sodium consumption in patients with heart failure. In Chapter 2 we present a study
conducted to examine the association between sodium consumption and medications
commonly prescribed to patients with HF. Specifically, we examined associations with
angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers
and diuretics, antihypertensive medications that are known to reduce sodium taste
sensitivity. Linear regression was conducted in order to examine predictors of sodium
consumption using sodium density as a proxy, controlling for age, gender, ethnicity,
BMI, and NYHA class.
Current literature contains little information regarding the association of
TAS2R38 haplotype with adherence to daily recommendations for sodium, sugar, or
saturated fats, as well as consumption of vegetables and alcohol. Chapter 3 is a study in
which we examined associations between haplotype variants of the TAS2R38 gene and
sodium consumption as well as the consumption of other nutrients including saturated fat,
sugar, alcohol, and vegetable consumption. This was a secondary analysis of data from a
study conducted with community dwelling individuals with two or more cardiovascular
disease risk factors. We hypothesized that people with one or two PAV haplotypes of the
TAS2R38 gene, associated with greater bitter taste sensitivity, would have greater sodium,
sugar, and saturated fat consumption than those with the AVI haplotype because they add
greater salt or sugar in order to offset the bitter taste of food. Because alcohol and
vegetables have greater bitter taste properties, we also hypothesized that those with the
9

PAV haplotype would have decreased consumption of these compared to those who were
homozygous for the AVI haplotype.
There is little known regarding the associations of salt taste sensitivity, fungiform
papillae density, and sodium consumption among patients with heart failure and their
family caregivers. Chapter 4 is a study in which we examined the association of TAS2R38
genotype, salt taste sensitivity, and dietary sodium consumption in patients with heart
failure and their family caregiver. We hypothesized that those with the PAV haplotype
would be more sensitive to salt taste and would have lower 24-hour urinary sodium
excretion. Linear regression was conducted to examine predictors of salt taste sensitivity
and 24-hour urinary sodium excretion controlling for age, gender, ethnicity, smoking
status, and fungiform papillae density.
Chapter 5 is a synthesis of the results of our studies and a discussion of their
impact on the state of the science of taste perception factors and their relationship with
dietary consumption of key nutrients that affect heart health such as sodium. This
dissertation provides evidence of the importance of understanding factors that alter taste
perception and their associations with eating behavior both in healthy individuals and in
those with cardiovascular disease.
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CHAPTER TWO:
Dietary sodium intake is predicted by anti-hypertensive medication regimen in
patients with heart failure
Introduction
In patients with heart failure, self-care is pivotal to appropriate management of the
condition including adhering to a low sodium diet.46 Unfortunately, many patients with
heart failure do not follow the recommended low sodium diet with rates of adherence
reported to be as low as 22%.12,46-53 Patients have identified taste of food as one reason
for not adhering to this recommendation.54,55 Most patients report that reducing salt
makes food unpalatable and limits the enjoyment of eating, negatively affecting quality
of life. 54,55
Salt taste sensitivity, defined as the ability of an individual to identify the taste of
sodium, is comprised of two dimensions: recognition and detection.34 Recognition is the
minimum amount of salt required to identify sodium in a food; detection is the minimum
amount of salt required to detect a change in amount of sodium in a food.34 Salt taste
sensitivity is a complex phenomenon that is affected by factors that include neural,
chemical, and structural inputs which can be altered by external factors such as
medications, dietary salt intake, or health conditions such as heart failure.34,56,57 Some
antihypertensive medications and cardiac drugs, including angiotensin converting
enzyme (ACE) inhibitors commonly prescribed in heart failure, cause a decrease in salt
taste sensitivity,34,45,58 which may result in increased salt consumption.45,59-61 However,
the relationship between angiotensin converting enzyme (ACE) inhibitors and salt
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consumption has not been well-studied. Therefore, the purpose of this study was to
examine if prescription of an ACE inhibitor predicted sodium consumption. We
hypothesized that sodium consumption (as calculated based on amount of sodium
consumed per kilocalorie or sodium density), would be higher in patients with heart
failure prescribed ACE inhibitors than in patients who were not prescribed ACE
inhibitors.
Methods
Design. This was a secondary analysis of data from patients with heart failure
enrolled in an observational longitudinal study examining the relationships between body
fat mass, body fat distribution, cytokine activity, and nutritional intake.
Sample. Data from 255 patients were included in this analysis. Patients were
recruited from three large academic healthcare facilities; two located in the southeastern
region of the U.S. and one in the midwestern region. Inclusion criteria were: (a)
confirmed diagnosis of chronic heart failure and (b) ability to read and speak English.
Exclusion criteria were: (a) valvular heart disease as a cause of the heart failure; (b)
myocardial infarction within the last 3 months; (c) referral for heart transplant; (d)
uncontrolled diabetes mellitus (HgA1c > 8%); (e) presence of illness associated with
systemic inflammation, weight loss, or decreased appetite; or (f) cognitive impairment
that prevented giving informed consent.
Measurement of Variables.
Demographic and Clinical Data. Participant demographic data including age,
gender, race/ethnicity, and smoking status were collected through self-report via a
12

sociodemographic questionnaire. New York Heart Association (NYHA) class and
prescribed medications (i.e., ACE inhibitors) were ascertained by trained research nurses
using a structured patient interview. Body mass index (BMI) was ascertained using the
standard kg/m2 formula as BMI has been linked to excessive sodium consumption in
prior research.62
Dietary Sodium Consumption. Dietary sodium consumption was defined as the
averaged four-day sodium intake divided by averaged four-day kcal intake. This was
chosen as the metric for salt consumption because it controls differences in sodium
consumed due to differences in amount of food consumed and is a better indicator of
patients’ preferred saltiness of food. Nutritional data were collected by weighed food
diaries that patients completed for a four-day period, including three weekdays and one
weekend day. The use of four-day food diaries is a valid method from which nutrients in
the diet, including sodium, can be measured.60,63 Prior to recording food diaries, patients
met with a research assistant in their homes who, using food models and pictures of
appropriate portion sizes, instructed the patients how to accurately weigh and record
dietary information. Each participant was given an electronic digital scale for accurate
recording of portion sizes. At the end of the four-day food diary collection, patients met
with a dietitian who collected missing information, verified serving sizes, and verified
food preparation methods. Food diaries were analyzed using the Nutrition Data System
for Research software (NDS-R 2007; NRCC, Minneapolis, MN).
Procedure.
Approval for this study was obtained from the Institutional Review Boards at each
study site. Patients were recruited from affiliated outpatient clinics after referral from a
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nurse or physician. After providing written informed consent, patients were visited in
their homes and instructed how to complete four-day food diaries. The morning after
completing diaries patients visited the Clinical Research Center to provide demographic
and clinical data and review food diaries with a dietitian.
Data Analysis.
Patients were categorized into two groups: those who were prescribed ACE
inhibitors and those who were not. Differences in demographic and clinical
characteristics and in dietary sodium consumption between the two groups were
compared using independent t tests or chi square as appropriate. A multivariable linear
regression was conducted to determine whether prescribed ACE inhibitors independently
predicted dietary sodium density. In the model we controlled for age, gender, ethnicity
(non-Hispanic whites vs other races), BMI, NYHA class (I-IV), smoking status (smokers
vs non-smokers), prescribed beta blocker, prescribed angiotensin II receptor blocker
(ARB) and prescribed diuretics. All independent variables were entered into one model
for analysis. An alpha of 0.05 was set a priori.
Results
Sample characteristics. The majority of patients were white males with slightly
more than half in NYHA class I/II. Mean BMI was 29.7 + 6.8. Diuretics (74.5%), beta
blockers (88.6%), and ACE inhibitors (69.8%) were commonly prescribed, but fewer
than a quarter of patients were prescribed an ARB. Sample characteristics and
comparisons between patients who were and were not prescribed an ACE inhibitor are
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presented in Table 2.1. The only significant between-group differences were that more
males were prescribed an ACE inhibitor and a beta blocker than females.
Patients prescribed an ACE inhibitor consumed approximately 13% more sodium
per kcal than patients who were not prescribed an ACE inhibitor (1.8 ± 0.6 mg
sodium/kcal vs. 1.6 mg ± 0.4 sodium/kcal; p = .001). In our regression model,
prescription of an ACE inhibitor predicted higher dietary sodium consumption (b =.230,
t(234) = 2.566, p = .011, controlling for age, smoking status, ethnicity, NYHA class, and
other prescribed medications [Table 2.2]). R2 for the model without ACE inhibitors was
0.038 and when ACE inhibitor was added to the model R2 changed to 0.057, accounting
for 5.7% of the variance in the data. No other medications predicted dietary sodium
consumption.
Discussion
In support of our hypothesis, prescription of an ACE inhibitor predicted higher
consumption of sodium per kcal. In accord with current practice guidelines,64,65 patients
with heart failure are commonly prescribed medications including ACE inhibitors in
conjunction with a low sodium diet.64 However, as indicated by the results of our study,
prescribing ACE inhibitors may present a barrier to low sodium diet adherence.
Supporting our findings are studies that have shown ACE inhibitors are associated with
taste disturbances.34,45,66 Taste disturbances most commonly associated with ACE
inhibitors range from taste loss, to alteration of salty, sweet, or metallic tastes that include
a lingering taste in the mouth or taste confusions such as sweet for salty or sweet for
bitter.58,67,68 These disturbances may result in lowered salt taste sensitivity and increased
salt consumption.60
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Other medications are also suspected to produce taste disturbances, such as
ARBs, diuretics, and beta blockers.34,45 However, similar to other studies,34 only ACE
inhibitors predicted sodium consumption of diets in our patients with heart failure. The
effect of ACE inhibitors may be exacerbated by heart failure induced over-activation of
the renin-angiotensin-aldosterone system (RAAS), with angiotensin II and aldosterone
implicated in inducing salt appetite in response to changes in sodium concentration.34,56
ACE inhibitors work by preventing the conversion of angiotensin I to angiotensin II.
ACE inhibitors are also known to chelate serum zinc which results in depletion of zinc
levels.69 It is possible that the depletion of zinc that occurs with the chelating action of
ACE inhibitors causes a disturbance in the functioning of gustin, a protein necessary for
the healthy growth and differentiation of taste buds,70 which in turn produces a
disturbance in salt taste. This could be the mechanism by which ACE inhibitors induce
taste disturbances: by serum zinc concentration dependent mechanisms.69,71
In contrast, ARBs work by selectively blocking angiotensin II from binding to
receptors but have not been linked to serum zinc depletion.45,67 This may explain why
prescribed ARBs did not predict dietary sodium density. Although some diuretics have
also been linked to salt taste sensitivity alteration, this has only been demonstrated for
diuretic medications that are less commonly prescribed today. For example, the
potassium-sparing diuretic amiloride, rarely used today among patients with heart failure,
was hypothesized to block ion channels in the taste receptor membrane altering the flow
of sodium ions.67 The majority of patients in our study were prescribed loop diuretics
which have not been associated with salt taste sensitivity, as supported by our findings.
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de Souza et al. reported that patients with heart failure may have a greater
preference for salt in their food56. These authors further suggested that because most
patients with heart failure have taken multiple medications over a long period of time,
the medication could affect the palatability of food, although the authors do not define the
length of time or the particular medication.56 Consequently, patients with heart failure
taking a medication that reduces the ability to taste the salt in their food34 may need to
use more salt to meet their already heightened preference. This behavior, in turn, can
increase the risk of heart failure exacerbation. Our results suggest that ACE inhibitors
may be one of those medication.
BMI was the only other variable in the model that was found to be a significant
predictor of sodium density in the diet. This is not a surprising finding as sodium has
been linked to BMI previously. In particular, excessive sodium consumption is thought to
be linked with high calorie foods and the consumption of sugar sweetened beverages
which can lead to being overweight or obese.62,72 Specifically, sodium consumption in
patients with heart failure has been linked to fluid retention which in turn leads to
increasing weight.73 Our results confirm previously reported associations between BMI
and sodium consumption.62,72,73
Our finding that gender was not a significant predictor of sodium density may
appear to be contrary to findings from previous studies in which men were shown to have
higher rates of non-adherence to low sodium diet.50 However, because the amount of
sodium consumed is tied to the amount of food consumed, using sodium density instead
of total sodium intake controlled for differences in amount of food consumed between
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men and women. Consequently, this method allowed us to directly compare level of
sodium in food between men and women.
The findings from our study can inform educational efforts. Understanding that
ACE inhibitor use is associated with an increase in sodium consumption per kcal possibly
due to alteration in salt taste sensitivity will allow providers to preemptively plan for this
side effect. For example, some researchers have shown that prescribing zinc with ACE
inhibitors may decrease the influence on salt taste sensitivity.69 The reason for this may
be due to an effect of ACE inhibitors that is thought to alter zinc at the receptor level
which changes the conversion of angiotensin I to angiotensin II because zinc is necessary
for the catalytic action of angiotensin converting enzyme.56,67,74 In addition, taste
disturbance is linked to zinc deficiency which may explain why this drug produces the
effect.34,66,69,75 Depletion of zinc interferes with production of gustin, a protein which is
necessary for the growth and development of healthy taste buds; without gustin there are
fewer taste buds.76 Likewise, when educating patients with heart failure, consideration of
possible taste disturbance may allow health care providers to be more specific when
discussing the barrier of taste change when patients attempt to alter their diets. Providers
may be able to offer advice on how to acclimate to decreased sodium in the diet while
also dealing with a possible decrease in sensitivity to the taste. More research is required
to further refine information regarding the association of ACE inhibitor use and sodium
consumption as well as to develop educational interventions aimed at helping those on
ACE inhibitors decrease their sodium consumption.
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Conclusions
The finding that prescribed ACE inhibitors predicted sodium consumption of
patients with heart failure has implications for interventions to improve heart failure selfcare. Aware of the potential alteration of sodium consumption associated with ACE
inhibitors, nurses and other health professionals can closely monitor dietary sodium
intake of patients prescribed ACE inhibitors and provide appropriate education and
interventions. These measures can better support heart failure patients’ adherence to low
sodium diet recommendations thereby decreasing the risk of heart failure exacerbation
and rehospitalization.
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Table 2.1. Sample Characteristics by Angiotensin Converting Enzyme inhibitor (ACEi)
grouping.
Total Sample
Not
Prescribed
Characteristic
(N=255)
prescribed
ACEI
P-value
ACEi
(n=178)
(n=77)
Age (years)
61.1 ± 11.8
61.2 ± 12.2
61.0 ± 11.7
.39
Gender (male)
174 (68.2%)
42 (54.5%)
132 (74.2%)
.003
Ethnicity (White)
185 (72.5%)
54 (70.1%)
131 (73.6%)
.64
Smoker (current or
66 (25.9%)
23 (29.9 %)
43 (24.2%)
.35
recent)
NYHA class (III/IV)
112 (43.9%)
32 (41.6%)
80 (44.9%)
.78
2
BMI (kg/m )
29.7 + 6.8
29.4 + 7.0
29.8 + 6.7
.51
Prescribed diuretic (yes)
190 (74.5%)
59 (76.6%)
131 (73.6%)
.87
Prescribed beta blocker
226 (88.6%)
64 (83.1%)
162 (91.0%)
.08
(yes)
Prescribed angiotensin
48 (18.8%)
41 (53.2%)
7 (3.9%)
.001
receptor blocker (yes)
Data are mean ± SD or n (%), Angiotensin Converting Enzyme Inhibitor (ACEi)

20

Table 2.2. Predictors of Dietary Sodium Density
b (CI)
.000 (-.006, .006)
.047 (-.097, .190)
-.113 (-.274, .047)

SE
.003
.073
.082

β
-.007
.042
-.096

P value
.925
.523
.166

Age (years)
Gender (male reference group)
Ethnicity (non-Hispanic White reference
group)
Smoking (past or never smoke reference
.101 (-.062, .264)
.083
.085
.225
group)
NYHA Class (Class I/II reference group,
.021 (-.115, .158)
.069
.020
.758
III/IV non-reference group )
BMI (kg/m2)
.018 (.007, .028)
.005
.224
.002
Prescribed diuretic (not prescribed
.077 (-.082, .237)
.081
.064
.339
reference group)
Prescribed beta blocker (not prescribed
-.092 (-.296, .112)
.104 -.056
.376
reference group)
Prescribed angiotensin II receptor
.005 (-.201, .212)
.105
.004
.959
blockers (not prescribed reference group)
Prescribed angiotensin converting
.230 (.053, .406)
.089
.204
.011
enzyme inhibitors (not prescribed
reference group)
Note. The dependent variable was sodium density. R2 for the full model = .070, p = .044.
New York Heart Association (NYHA), Body Mass Index (BMI)
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CHAPTER THREE:
Dietary Consumption of Sodium, Sugar, Saturated Fat, Alcohol, and Vegetables is
Not Predicted by TAS2R38 Haplotype
Introduction
Cardiovascular disease (CVD) is the number one cause of death in the United
States and costs our healthcare system $320 billion dollars per year.2,77 The most
effective way to decrease rates of CVD is through prevention that targets risk factors such
as obesity, physical inactivity and smoking.78 Unhealthy diet is among the risk factors
critical to target in risk reduction strategies. The association of diet with CVD risk is
well-known. Excessive intake of sodium has been linked with hypertension,
cardiovascular disease and stroke7,8 while reduction of sodium has associations with
lowering of blood pressure.6 Excessive intake of sugar is not necessary for our health and
provides no nutrients to our bodies.79 Reducing saturated fat intake has been shown to
reduce low density lipoprotein cholesterol80, which has been linked to an increase of
CVD risk though adherence to the artery walls.81 Increased consumption of alcohol can
lead to hypertension, heart failure, and increased calorie intake.82 Research has shown
that vegetables in the diet are associated with a reduction of risk for many chronic
diseases and certain types of cancer.49
Although essential to maintenance of good health and prevention of CVD, the
diets of most people in the United States are poor. For example, the average sodium
consumption for American adults is double the American Heart Association (AHA)
recommendation of no more than 2,400 milligrams (mg) per day.78,83 According to
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USDA guidelines, less than 10% of daily calories should come from sugars or saturated
fats. Despite this, the average adult consumes 13% of their calories from sugars and 11%
from saturated fats per day.49 Similar patterns are seen with alcohol and vegetable intake.
According to data from the 2016 Behavioral Risk Factor Surveillance System (BRFSS),
16.5% of U.S. adults overindulge in alcohol, consuming on average more than 4 drinks
per day despite recommendations that men have no more than 2 drinks per day and
women no more than 1 drink per day.84 According to data from the 2016 BRFSS, most
adults in the U.S. don’t consume adequate amounts of fruits and vegetables.49,84
Much research has been conducted to better understand dietary choices including
studies examining the influence of socioeconomic status,85 access to healthy food
choices,86 food preparation time and knowledge,87 and culture.88 Less studied has been
the role of the taste of foods that in turn can affect food choices and eating patterns.
Among the few studies conducted, important patterns emerge regarding the importance of
taste. In experiments where participants were asked to rate the importance of food taste
when considering items for purchase, 77% rated taste as very important.89 Healthier food
choices have been frequently identified as being less desirable due to poor taste. For
example, although following a low sodium diet is critical to lowering risk for heart failure
exacerbation, adherence to low sodium diet is difficult for many patients with this
condition due to the perception of low sodium foods as not tasting good.54,55,90
Taste is a unique sense that varies greatly among individuals and cultures. It is an
important factor in decisions regarding food choices and eating behavior.15 Taste
preferences are based on learned patterns, social behavior, and genetic variations in taste
receptors.15 The emerging science of genetics in taste perception and sensation holds
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promise for elucidating the underpinnings of the wide variation of taste preferences
between individuals. Differences in genotype can produce variation in proteins that
determine the structure and function of taste receptors in the tongue.25,43,91 Taste
receptors, in turn, have a central role in the detection and processing of flavors in foods
and are ultimately responsible for variations in the 5 taste modalities: salty, sweet, bitter,
sour, and umami, or savory. Genetic variations can result in differences in taste receptors
that in turn may lead to differences in how flavors are perceived.
One of the most well studied genetic variations that influence taste is the
TAS2R38 gene which codes for a bitter taste receptor and is known to enhance the taste of
glucosinalates in food and the associated 6-n-propylthiouracil (PROP) chemical that is
sensed as bitter.18,91,92 The two well characterized haplotypes of the TAS2R38 gene are
the PAV and the AVI haplotype. The ability to taste these two chemicals varies greatly
depending on which haplotype of the TAS2R38 gene is inherited. The PAV haplotype
results in the two chemicals tasting especially bitter while the AVI haplotype results in
the chemicals having no taste. Approximately 70% of people have at least one copy of
the PAV haplotype and are able to taste bitter properties of foods and chemicals (referred
to as the taster phenotype) whereas 30% are homozygous for the AVI haplotype and are
unable to taste these properties (referred to as the non-taster phenotype).18,91 While these
haplotypes are known to affect bitter taste perception and have been associated with
patterns of cruciferous vegetable consumption, very little is known regarding their
association with other perceived tastes including sodium, sugar, fat, and alcohol despite
known associations with taste intensity of other taste modalities of sour, salty, and
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sweet.93 Similarly, the association between haplotype and vegetable consumption in
general has not been well investigated.
Therefore, we conducted a study to better understand the potential role of the
PAV and AVI haplotypes in dietary patterns. The purpose of this study was to examine
associations of the TAS2R38 haplotype with daily sodium, sugar, saturated fat, and
alcohol intake in adults with two or more CVD risk factors. We hypothesized that
compared to people who are AVI homozygous, those who are heterozygous or
homozygous for the PAV haplotype would a) be less likely to meet standard dietary
recommendations for sodium, sugar, and saturated fat consumption and b) would have
lower vegetable and alcohol intake.
Methods
Design, Sample and Setting. This was a secondary analysis of baseline data from
344 participants in the Gene Environment Interactions Regulating CVD Inflammation
and Success of Behavioral Therapies. The original study was conducted to examine the
effects of genotype on responses to a self-management intervention to reduce CVD risk
among rural community-dwelling populations at-risk for CVD. Participants were
included who had 2 or more CVD risk factors including unhealthy diet, being physically
inactive, being overweight or obese; being a current smoker; age 45 years or older for
males and 55 years or older for females; having a family history of heart attack or stroke;
having diagnosed hypertension, diabetes, or abnormal lipids; or experiencing depression
or anxiety. Patients were excluded if they 1) were taking medication that interfered with
lipid metabolism, 2) were cognitively impaired, 3) were non-English speaking, 4)
suffered from chronic drug abuse, 5) had end-stage renal, liver, or pulmonary disease, 6)
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had current, active cancer, 7) had a GI disease that required a special diet, 8) had any
condition that prohibited physical activity, or 9) had known coronary artery disease or
genetic or congenital heart disease. Data analyses were limited to those who selfidentified as Caucasian (>92% of participants) to control for population stratification.
Carriers of the dominant PAV haplotype on the TAS2R38 gene were compared to nonPAV carriers, i.e., AVI homozygotes; participants with rare non-PAV or AVI haplotypes
were excluded from analyses for a total of 211 participants.
Measures
Demographics: Age, gender, smoking status, and medications were assessed
using self-report. These factors were included as they have been previously reported to
have associations with taste perception.44,94,95
Body mass index (BMI): Weight was measured on a professional digital scale and
height on a stadiometer with participants in light clothing and shoes removed. BMI was
calculated as weight in kilograms divided by height in meters squared.
Dietary intake patterns. Data on dietary intake of sodium, sugar, saturated fats,
alcohol and vegetable consumption were obtained using the Viocare Food Frequency
Questionnaire (FFQ). Evidence has shown web-based FFQs to be a reliable method for
estimating dietary quality.96 This web-based, self-report, food frequency questionnaire
was completed by participants on computer. Participants indicated how often foods were
consumed over the past 90 days as well as portion sizes. Questions covering how food
was purchased and prepared were also included to more accurately calculate nutrient
intake. Participants opted to complete the questionnaire independently during the baseline
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data collection period or to have questions read aloud by a research nurse who then
completed the instrument based on participant responses. The FFQ were analyzed using
NDSR (Nutrition Data System for Research) software which provided output on the
number of portions of vegetables consumed daily as well as milligrams of sodium, grams
of sugar and saturated fats, and number of alcoholic drinks consumed daily.
DNA. DNA was obtained from expectorated saliva collected using Oragene-DNA
Collection Kits (DNA Genotek Inc., Ottawa, Ontario, Canada). Saliva has been shown to
be as accurate as whole blood for DNA isolation and genotyping, to have lower
participant burden,97-100 and to provide high quantity and quality DNA.101,102 DNA was
quantified by UV absorbance with a Nanodrop. Genotyping was performed using
Taqman® according to manufacturer’s instructions. Primers and probes (FAM and VIC
labelled) were supplied by Life Technologies. DNA samples were genotyped in a
genetics lab with capacity to isolate, genotype, and appropriately store genetic material.
The DNA samples were pipetted onto a 96 well plate. Genotypes were determined using
an MJR Chromo-4 RT-PCR system (MJ Research). Two SNPs, rs713598 and rs1726866,
from the TAS2R38 gene were genotyped using samples from all participants who
consented to DNA analyses. These SNPs are associated with the PAV/AVI haplotype and
code for the first and second positions respectively. The third SNP, rs10246939 was not
genotyped because it is in perfect linkage disequilibrium with the rs1726866 SNP. Both
SNPs genotyped have been associated with enhanced bitter taste perception.
Procedure
Approval from the Institutional Review Board was obtained prior to initiating the
study. All participants gave informed consent before baseline data were collected
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including demographic data through self-report questionnaires, clinical measurements,
FFQ, and the Oragene kit for saliva DNA sample. Patients were randomized to
intervention and control group then post-intervention data were collected. For this
secondary data analysis, only baseline data from participants who had provided a DNA
sample were included.
Data Analysis Dietary intake of each of the dietary components of interest was
categorized as either adherent or non-adherent to the United States Department of
Agriculture (USDA) Dietary Guidelines49 for intake for sodium (≤ 2.3 g), sugar (< than
10% of total calories [kcal]), and saturated fats (<than 10% of total kcal). Alcohol and
vegetables were taken from the FFQ as number of servings per day consumed. Patients
were grouped by TAS2R38 genotype as either a) PAV homozygous or heterozygous or b)
AVI homozygous. To ascertain differences between groups, independent t -tests and chi
square analyses were conducted as appropriate for the level of measurement. Logistic
regressions were conducted to examine whether genotype predicted adherence to dietary
recommendations for sodium, sugar, and saturated fat. We controlled for factors that
affect taste including age, gender, smoking status (current or recent smokers compared to
past or never smokers), BMI, and prescribed angiotensin converting enzyme inhibitor
(ACEi) (yes/no) and angiotensin II receptor blocker (ARB) medications (yes/no). Linear
regressions were used to examine whether genotype predicted consumption of alcohol
and vegetable intake, controlling for factors previously delineated that affect taste and
dietary intake (age, gender, smoking status, BMI, and prescribed ACEi and ARB
medications). Data were analyzed using SPSS, v. 24. An alpha level of 0.05 was used for
all analyses.
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Power considerations. An a priori power analysis indicated that with alpha equal
to .05 and a sample size of 125 (representing an anticipated 38 participants with at least
one PAV dominant haplotype and 87 heterozygous or homozygous AVI individuals), the
power for group comparison of genotypes would be at least 85%, assuming the ratio of
the standard deviation of the group means to the standard deviation of the observations
within the populations is as small as 0.36; this effect size was more modest than that
reported previously in a similar study.103
Results
Sample Characteristics. Of the 211 participants (mean age 52.0±13.4 years;
73.5% female), the majority were overweight or obese (mean BMI 32.9 kg/m2 ± 7.7 and
non-smokers (84.4 %); 22.3% were taking ACEi and 3.3% ARB; 82.5% were
homozygous or heterozygous for the PAV haplotype. The percentage of participants who
met daily recommended intake of sodium, consuming <2.3 g/day was 18%; 1.6% of
participants consumed <10% of their calories of sugar and 25.1% of participants
consumed <10% of their calories as saturated fats. Mean alcohol consumption was 2.9 +
9.6 drinks per day. Mean vegetable consumption was 1.4 + 1.3 servings of vegetables per
day. As shown in Table 3.1, there were no significant group differences in characteristics
between participants who were homozygous or heterozygous for the PAV haplotype and
those who were homozygous for the AVI haplotype.
Predictors of Dietary Intake Patterns. Neither the PAV nor the AVI haplotype
was predicted dietary intake of sodium, sugar, saturated fats, alcohol or vegetable
consumption (Tables 3.2, 3.3, 3.4, 3.5, and 3.6). In the logistic regression models, BMI
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was the only significant predictor of adherence to dietary sodium recommendations
(p=0.014) and saturated fat recommendations (p=0.015).
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Discussion
We examined adherence to standard dietary sodium, sugar, and saturated fat
recommendations as well as dietary intake patterns of vegetables and alcohol in adults as
a function of the PAV and AVI haplotype of the TAS2R38 gene. Our hypotheses that
people who were heterozygous or homozygous for the PAV haplotype would be less
likely to adhere to recommended sodium, sugar, and saturated fat consumption and would
have lower vegetable and alcohol consumption than those who were homozygous for the
AVI haplotype were not supported. We found no significant difference between
haplotypes on adherence to dietary recommendations for consumption of sodium, sugar,
or saturated fats. Likewise, neither alcohol nor vegetable consumption was significantly
different between those with the PAV homozygous or heterozygous haplotype and those
who were AVI homozygotes. Results of other studies have demonstrated links between
the taster phenotype due to the PAV haplotype and intensity of sodium taste.93,104 People
with the taster phenotype that corresponds to PAV homozygous individuals (PROP
supertasters) tended to taste greater intensity of sodium over those with the phenotype
that corresponds to the AVI homozygous haplotype (PROP nontasters).93,104,105 Hayes et
al. also showed that PROP supertasters were also more likely to detect differences in
sodium at lower concentrations than PROP nontasters and showed greater dislike for
sodium at higher concentrations.104 In a prior study, salt sensitivity was positively
correlated with sensitivity to bitter chemicals associated with the PAV haplotype of the
TAS2R38 gene106 and this would suggest that the haplotype may also have a relationship
to salt taste perception. While these studies examined food taste testing in the laboratory,
they did not examine sodium consumption in day to day life. In our study, we found no
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relationship between TAS2R38 haplotypes and preference for foods higher in sodium
among community dwelling adults. This may indicate that experiencing greater salt
intensity does not translate to food selection and increased sodium consumption, despite
its relationship with greater dislike of highly concentrated salt.
Similar to studies of sodium consumption, prior studies have also demonstrated an
association between TAS2R38 haplotype and sugar consumption. Specifically, it has been
demonstrated that the homozygous PAV haplotype was associated with significantly
higher consumption of sugar in both children107 and adults.107 Furthermore, PROP
supertasters, have been shown to have higher fat and calorie intake when compared to
non-tasters, indicating that the same difference could be seen between PAV homozygotes
and AVI homozygotes.108 Additionally, TAS2R38 haplotype was associated with
vegetable intake in college students,27 higher intakes of folate and vitamin B6 (found in
green leafy vegetables) in women,44 and higher vegetable consumption in a sample of
adults in Brazil.27,107-109 The PAV homozygous haplotype has also been associated with
avoidance of such bitter tasting foods as cabbage, broccoli, coffee, tea, chocolate, and
alcoholic beverages.27,110
While the relationship between TAS2R38 has been confirmed in many studies,
results of other studies have not confirmed these conclusions. In their study of dietary
patterns in Irish children, O’Brien et al found that while bitter taste perception may have
influenced some individual food consumption, it did not affect overall dietary patterns.111
Furthermore, Risso et al found in their study of smoking behaviors and TAS2R38
haplotype that genotype was only related to smoking behaviors in European Americans
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and not in African Americans.112 These contradictory findings emphasize the need for
further research into the relationship between haplotype and eating behavior.
There may be many reasons that, in contrast to previous studies, we did not find a
relationship between TAS2R38 haplotype and sodium, sugar, fat, vegetable or alcohol
consumption. Given that our sample was drawn from a rural population of low
socioeconomic means, socioeconomic variables not accounted for in our analyses could
be more important moderators of diet than taste preferences conferred by the TAS2R38
haplotype. For example, rural populations such as participants in our study frequently
have limited access to healthy foods compared to urban populations.113 These populations
are often served by smaller grocery store chains that are less likely to stock fresh fruits
and vegetables and hence may be food deserts.114 Access is also closely related to the
lower socioeconomic conditions common in rural areas.113 As has been noted in previous
studies, those who live in food deserts spend more money on low quality food items and
less money on fresh vegetables and fruits.114 It is possible that our participants were
burdened by poor access to healthy foods and this factored more strongly into their food
choices.
Our findings may also suggest that there is a different mechanism for taste
modalities with PROP taster phenotype that is not associated with TAS2R38 haplotype.
This is likely as density of fungiform papillae, the number of taste buds on the tongue,
was previously thought to correspond with TAS2R38 haplotype but has since been found
to operate through a separate mechanism.18 Indeed, greater taste intensity could be related
to the greater fungiform papillae density that has been found to accompany PROP
supertaster phenotype, which appears independently of TAS2R38 haplotype.
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A limitation to our study was that, as this was a secondary analysis, we did not
have data available on PROP taster phenotype and fungiform papillae number, which
would have important control variables. Another limitation was that, because our sample
was comprised of Caucasians of European descent, our findings are not generalizable to
other racial and ethnic groups. Likewise, the sample was primarily female and thus may
not generalize to males. Finally, it is important to note that FFQs are not a reliable
measure of sodium intake. However, as this project is comparing across groups, the use
of relative amounts of sodium are sufficient as each individual was measured in the same
way.
Conclusions
In this study, TAS2R38 haplotype was not found to independently predict
adherence to recommended dietary intake of sodium, saturated fats, or sugar nor did it
predict intake of vegetables or alcohol. These findings may indicate that other
physiological as well as socioeconomic factors play a stronger role in these dietary
behaviors. Future research to elucidate the contributions of TAS2R38 haplotype to eating
behaviors should consider a wider array of social and behavioral variables, such as taster
phenotype, and fungiform papillae density. Also, because PROP phenotype has been
shown to be a strong predictor of food choices and is easy to determine using an
inexpensive non-invasive test, it may be more beneficial to examine PROP phenotype in
future studies rather than genotype alone.
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Table 3.1: Demographic Characteristics by TAS2R38 Haplotype
Mean ± SD or % (n)

Total Sample
N=211

PAV/PAV or
PAV/AVI
(n=174)

AVI/AVI
(n=37)

P
value

Age

52.0 ± 13.4

51.9 ± 13.1

51.5 ± 14.9

.287

Gender (female)

73.5% (155)

71.8% (125)

81.1% (30)

.308

BMI

32.9 kg/m² ± 7.7

32.9 ± 8.0

32.5 ± 6.4

.154

Smoking status

84.4% (178)

82.2% (143)

94.6% (35)

.079

Prescribed ACEi (yes)

22.3% (47)

22.4% (39)

21.6% (8)

.830

Prescribed ARB (yes)

3.3% (7)

2.9% (5)

5.4% (2)

.619

Sodium (mg)

3785.1 + 1939.7

3837.0 + 2003.4

3540.8 + 1608.4 .593

Saturated fats (g)

30.5 + 19.8

31.1 + 20.6

27.6 + 15.7

.262

Sugars (g)

138.6 + 117.2

141.5 + 124.9

125.0 + 69.8

.215

Alcohol (servings per

2.9 + 9.6

2.7 + 8.3

3.7 + 14.2

.237

1.4 + 1.3

1.2 + 1.1

1.9 + 1.6

.021

(non-smoker)

day)
Vegetables (servings
per day)
Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers
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Table 3.2: Predictors of Adherence to Dietary Sodium Consumption (<= 2.3g)
Variable

Odds Ratio

95% CI

P

Age

1.01

0.97 - 1.04

.537

Gender

0.52

0.18 - 1.49

.227

Smoking status (non-smoker)

2.71

0.58 – 12.76

.206

BMI

1.08

1.02 – 1.14

.014

Prescribed ACEi (yes)

0.53

0.21 – 1.35

.185

Prescribed ARB (yes)

0.84

0.90 – 7.91

.882

PAV Haplotype

1.12

0.43 – 2.91

.817

Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers; body mass index = BMI
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Table 3.3. Predictors of Sugar Consumption Adherence (<10% of total calories)
Variable

Odds Ratio

95% CI

P value

Age

0.95

0.85 – 1.06

.376

Gender

1.06

0.07 – 17.19

.965

Smoking Status (non-smoker)

0.03

0.01 – 0.80

.036

BMI

0.93

0.75 – 1.14

.461

Prescribed ACEi (yes)

59017904.46

0.00 – 0.00

.997

Prescribed ARB (yes)

43429086.94

0.00 – 0.00

.999

PAV Haplotype

6.69

0.29 – 151.79

.233

Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers; body mass index = BMI
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Table 3.4: Predictors of Saturated Fat Consumption Adherence (<10% of total calories)
Variable

Odds Ratio

95% CI

P value

Age

0.97

0.94 – 0.99

.039

Gender

0.61

0.26 0 1.46

.265

Smoking status (non-smoker)

1.05

0.35 – 3.14

.936

BMI

1.07

1.01 – 1.13

.015

ACEi Prescribed (yes)

1.13

0.48 – 2.67

.784

ARB Prescribed (yes)

1.99

0.22 – 17.89

.538

PAV Haplotype

0.66

0.26 – 1.69

.383

Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers; body mass index = BMI
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Table 3.5: Predictors of Alcohol Consumption (servings per day)
Variable

b (CI)

SE

β

P value

Age

0.08 (-0.03 – 0.18)

0.05

0.12

.135

Gender

-2.42 (-5.37 – 0.53)

1.49

-0.12

.107

Smoking Status

3.37 (-0.33 – 7.07)

1.87

0.13

.074

BMI

-0.14 (-0.30 – 0.03)

0.09

-0.12

.109

ACEi Prescribed

-0.54 (-3.60 – 2.52)

1.55

-0.03

.727

ARB Prescribed

-3.46 (-10.06 – 3.14)

3.34

-0.08

.302

PAV Haplotype

-1.91 (-5.09 – 1.28)

1.61

-0.09

.239

Model F = 1.981; R2 = 0.073; P = 0.060

Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers; body mass index = BMI
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Table3.6: Predictors of Vegetable Consumption (servings per day)
Variable

b (CI)

SE

β

P value

Age

0.01 (-0.01 – 0.03)

0.007

0.13

.090

Gender

0.06 (-0.32 – 0.44)

0.19

0.02

.754

Smoking status

-0.61 (-1.09 – -0.13)

0.24

-0.19

.012

BMI

0.00 (-0.02 -0.02)

0.01

0.001

.992

Prescribed ACEi

0.05 (-0.35 – 0.44)

0.20

0.02

.812

Prescribed ARB

-0.14 (-0.99 – 0.71)

0.43

-0.33

.745

PAV Haplotype

-0.09 (-0.49 – 0.32)

0.21

-0.03

.674

Model F = 1.764; R2 = 0.029; P = 0.097

Abbreviations: ACEi = angiotensin converting enzyme inhibitors; ARB = angiotensin
receptor blockers
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CHAPTER FOUR:
TAS2R38 Haplotype predicts 24-hour Urinary Sodium Excretion in Patients with
Heart Failure and their Family Caregivers
Introduction
Heart failure (HF) carries a significant burden of morbidity and mortality with 50%
likelihood of death within 5 years of initial diagnosis. It is also an economic burden,
resulting in an estimated $30.7 billion annually in health care expenditures,10 a substantial
portion of which is due to HF re-hospitalizations.11 Rehospitalizations are often related to
exacerbations that are preventable with appropriate self-care.46 Critical self-care activities
for HF include taking medication as prescribed, monitoring of symptoms, evaluating
symptom severity, and adhering to a low sodium diet (LSD).46 Adherence to LSD is of
particular concern because excessive sodium intake leads to fluid overload which is a
major reason for rehospitalization.12,46
Despite the importance, adherence rates are alarmingly low, with estimates of
nonadherence to LSD ranging from 22% to 51% in patients with HF.48-53 Adherence is
associated with numerous barriers including lack of information from providers about
diet, insufficient social support for dietary changes, and limited low sodium food
choices.54,55 Among the most commonly reported barriers, however, are altered taste of
and decreased pleasure derived from eating low sodium foods.54,55 54 Much research has
been conducted to improve patient education regarding LSD48-50,52-54,90 and more recently
to improve social support.49,115-121 Few studies have been conducted to elucidate genetic
and biological determinants of preference for higher sodium foods that may impede
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adherence. Identifying these determinants has the potential to guide the development of
personally tailored interventions to improve adherence to LSD among patients with HF.
Salt taste sensitivity and associated phenotypes and genotypes
Tastes experienced by humans are triggered by five distinct modalities: sweet, salty,
sour, bitter, and umami.15 Taste is mediated by receptors located in taste buds on papillae
on the surface of the tongue. The receptors bind with molecules to trigger sensory signals
that are transmitted to the brain and interpreted as particular tastes; G protein-coupled
receptors bind with molecules associated with sweet, bitter, and umami taste.17,122,123 Salt
taste is primarily detected through the epithelial sodium channel (ENaC)124 but also
involves other receptors.22,124,125
Because taste receptors are located in taste buds situated within papillae, taste
perception is also mediated by number and type of papillae. Fungiform papillae that are
located on the tongue’s anterior surface have a prominent role in taste perception. In
particular, fungiform papillae are associated with salt, bitter, and sweet taste. Greater
density of fungiform papillae is in part responsible for greater taste perception associated
with these modalities.94,126,127 Fungiform papillae density is an important variable to
consider when examining taste. Two bio-behavioral factors related to taste perception are
the focus of the proposed study, salt taste sensitivity and bitter taste perception.
Salt taste sensitivity. How acutely a person can taste salt, or the level of sodium
concentration at which a person perceives and identifies ‘salty’ taste is defined as salt
taste sensitivity.75,125 A person with high salt taste sensitivity is able to detect salty taste at
lower sodium concentration levels than someone with low salt taste sensitivity. There is a
wide range of salt taste sensitivity variability among individuals.32,128 One explanation for
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this is variations in number of fungiform papillae, with greater fungiform papillae density
associated with higher salt taste sensitivity.126
Genetic variants and salt taste. Genetic variants may also influence salt taste
sensitivity but those directly associated with salt taste have yet to be identified.75,125,129
However, a haplotype for bitter taste perception has been identified and may also
influence salt taste. This haplotype is associated with ability to taste glucosinalates in
food and the associated 6-n-propylthiouracil (PROP) chemical. Approximately 70% of
people are able to taste bitter properties of foods and chemicals (referred to as tasters)
whereas 30% are unable to (referred to as non-tasters).18,91 Tasters have higher salt taste
sensitivity but paradoxically consume more sodium than non-tasters.32 It has been
hypothesized that higher sodium consumption among tasters may be due to greater salt
taste enjoyment or that sodium may be used to mask the bitter taste of foods.130,131
Bitter taste perception is highly heritable18,91 and is influenced by the taste 2 receptor
member 38 (TAS2R38) gene that encodes the G protein-couple receptor associated with
bitter taste.92 Three common single nucleotide polymorphisms (SNPs) of the TAS2R38
gene (rs714598, rs1726866 and rs10246939) code for variations in amino acids at three
positions: Ala49Pro (alanine [Ala] or Proline [Pro] at amino acid position 49), Val262Ala
(valine [Val] or alanine [Ala] at amino acid position 262) and Ile296Val (isoleucine [Ile]
or valine [Val] at amino acid position 296), respectively. These single nucleotide
polymorphisms (SNPs) are in strong linkage disequilibrium, giving rise to one of two
common haplotypes: the proline-alanine-valine (PAV) haplotype, which is associated
with being a taster sensitive to bitter taste, and the alanine-valine-isoleucine (AVI)
haplotype, which is associated with being a non-taster who is not sensitive to particular
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bitter taste.18,132 In a U.S. sample of 980 White and African-American individuals, the
most common haplotypes were PAV at 43.1% and AVI at 41.2%.95 A worldwide study of
5,589 individuals from 105 populations similarly demonstrated that the PAV and AVI
haplotypes were most frequent with similar frequencies across populations.23 Reflecting
reported percentages of population tasters and non-tasters, genetic studies have similarly
demonstrated that ~69% of the population is heterozygous or homozygous for the PAV
and ~30% are homozygous for the AVI haplotype.92 The frequency of variation from
these haplotypes is rare.28
The importance of the PAV and AVI haplotypes for salt taste is as-yet not well
determined. While there is strong evidence of the association of haplotype variations with
ability to taste bitter, 18,132 and of associations between the ability to taste bitter and salt
taste sensitivity, evidence of associations between PAV and AVI haplotypes and salt taste
sensitivity is limited.29 Because taste sensitivity influences food selection and dietary
patterns, elucidating associations among taste-related genotypes and salt taste sensitivity
as well as dietary sodium intake in patients with HF may provide greater understanding
of barriers to LSD adherence. To our knowledge, no study of the associations of PAV
and AVI haplotypes with adherence to LSD in this population has been conducted.
Therefore, we examined whether TAS2R38 haplotypes predicted salt taste sensitivity and
dietary sodium intake among patients with HF controlling for age, gender, ethnicity,
smoking status, and fungiform papillae density. We hypothesized that a) participants with
the PAV haplotype would be more sensitive to salt taste than those who were
heterozygous of homozygous for the AVI haplotypes and b) participants with the PAV
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haplotype would consume less salt and would have lower 24-hour urinary sodium
excretion compared to the other two groups.

Methods
Design, Setting and Sample. This was a descriptive comparative study of salt taste
sensitivity and TASR38 genotype measured at baseline in the ongoing parent grant,
Effects of Family Sodium Watcher Program on Outcomes in Heart Failure PatientFamily Caregiver Dyads’ (FAMSWaP). The FAMSWaP study is a randomized,
controlled trial testing the effects of an intervention for the patient with HF and family
caregiver dyads to improve LSD adherence.
Participants for the FAMSWaP study were recruited from clinical settings in a
Southeastern state. Eligible participants had a diagnosis of chronic HF with either
preserved or reduced ejection fraction and were able to speak and write English. Patients
were excluded if they had: (1) major clinical cognitive impairment, (2) a co-existing
terminal illness, (3) referral for heart transplantation, or (4) a dietary prescription that
prevents following a 2 to 3 gram sodium diet. Major cognitive impairment was
determined through medical record screening for diagnosis of Alzheimer’s disease or
dementia. Eligible caregivers were included if they were: (1) a primary caregiver
identified by the patient, (2) the spouse, committed partner, or family member living with
the HF patient, (3) able to speak and understand English, and (4) without cognitive
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impairment of dementia and Alzheimer’s disease. We invited 46 patients with HF and
their family caregivers participating in the FAMSWaP study to take part in this study.
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Measures
Demographic and clinical variables. Data collected at baseline for the FAMSWaP
study included age, gender, smoking status, and heart failure diagnosis. These were
obtained via patient interview (age, gender, smoking status, caregiver characteristics) and
chart review (heart failure diagnosis).
Blood DNA collection, isolation, and laboratory analysis. We selected three SNPs
from the TAS2R38 gene that code for a G-coupled protein receptor: rs713598, rs1726866,
and rs10246939. DNA was isolated from whole blood sample using the Qiagen Blood
Mini Kit (Qiagen, Hilden, Germany). Whole blood is the gold standard for DNA isolation
and genotyping, and the Blood Mini Kit is sufficient to provide high quantity and quality
DNA.133-136 This test required 251 µL of blood which was collected via finger stick to
reduce participant burden. DNA was quantified by UV absorbance with a Nanodrop.137
Genotyping was performed using TaqMan® according to manufacturer’s instructions.
Primers and probes (FAM and VIC labelled) are supplied by Life Technologies. DNA
samples were plated out on a 96 well plate. Genotypes were determined using a CFX
Real Time PCR system (BioRad). The resulting data were analyzed for genotype and
allele frequency. Haplotypes were assigned based on genotyping analysis.
Salt taste sensitivity. Salt taste sensitivity is defined as the smallest concentration of
sodium at which the individual first perceives and can identify the ‘salty’ taste.75,125 This
was tested using the “up-down” procedure, a commonly used and reliable method.138 Salt
taste sensitivity is measured using 8 levels of salt (NaCl) concentration from 0.2% to
1.6% in samples of distilled water. To test sensitivity, room temperature samples
containing different salt concentration levels are served in 10 mL portions in a disposable
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cup marked with colored sticker dots not interpretable by patients and caregivers. In the
up trial, samples were given from lowest to highest salt concentration. Patients swished
samples in the mouth for 2 to 3 seconds, expectorated, and then judged the saltiness of
solution. The mouth was rinsed with 10 mL of distilled water between samples. When
patients detected salt taste in two consecutive samples, the lower concentration of the two
samples was recorded as the level of salt taste sensitivity. In the down trial, patients were
given samples in reverse order from highest to lowest concentration and when no salt
taste was detected in two consecutive samples, the level of salt taste sensitivity was then
recorded as the concentration of the immediately preceding sample. The level of salt taste
sensitivity was calculated by averaging the two sensitivity levels in the up and the down
trial.
Fungiform papillae density. Fungiform papillae density refers to the number of
fungiform papillae present on the tongue.91 The protocol for this test is based on the
Denver Papillae Protocol.139 Briefly, subjects rinsed the mouth with deionized water, the
tongue was dried with paper towel, and three ml of blue food dye at 1:36 concentration
was applied to the apex of the tongue using a sterile cotton swab. The subject was asked
to swallow to remove excess dye. With tongue protruding, a 2.5 cm piece of filter paper
with a 10 mm diameter center hole was applied to the left anterior side of the tongue next
to midline. Three close up images of the tongue were taken using a high quality digital
camera. Images were uploaded to a computer and analyzed using ImageJ software.
Personnel that counted the fungiform papillae were research nurses who were trained on
how to use the software and how to identify fungiform papillae. The fungiform papillae
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were counted under 50% magnification. This method has been demonstrated to be
reliable and valid in numerous studies.103,127,140,141
Adherence to LSD. 24-hour urinary sodium excretion provides an objective marker of
dietary sodium intake. Patients with HF in the study would have received a
recommendation for LSD adherence as part of the general education all HF patients
receive. Family member caregivers may or may not receive this information, but
according to general U.S. dietary recommendations, all people should be following a
LSD as well.49 As urine is the major route for sodium excretion with up to 98% of
dietary sodium excreted by the body through urine, urine sodium serves as a measure of
dietary sodium consumption.63 Dietary sodium intake is estimated through total amount
sodium excreted through the urine in 24 hours since most of the sodium taken in is
excreted in this manner. The 24 hour urinary sodium excretion has been used as a
validated measure of adherence to low-sodium diet.48-50,52,53,63 Patients and caregivers
received testing materials including a urine collection container and instructions at
enrollment and were asked to collect urine during the 24 hours prior to baseline data
collection. To reduce measurement errors, patients and caregivers received detailed
verbal instructions with a written instruction form and were asked to write down the time
of urination and amount of urine and to keep the collection container in a cool area.
Specimen containers were collected during the baseline data collection home visit. A
normal urinary sodium level is 40 to 120 mEq/L/d. To compare urine sodium excretion to
the recommended sodium intake (2000-3000 mg), urine sodium excretion in mmol were
converted into mg (mg = mmol x 22.99).
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Procedure
Approval from the Institutional Review Board was obtained before beginning the
study. All participants gave informed consent before baseline data were collected
including demographic data through self-report questionnaires, salt taste sensitivity,
fungiform papillae number, blood DNA sample, and 24-hour urine sodium excretion.
Patients were randomized to intervention and control group. Data was collected by
trained research assistants in the patient’s home. Fungiform papillae density was tested
first, then salt taste acuity was tested. Patients and caregivers were tested one at a time, in
separate rooms. For this analysis, only baseline data from participants who had provided
DNA sample, salt taste sensitivity, and fungiform papillae number were included.
Statistical Analyses
We conducted descriptive analyses including frequency, means, and standard
deviations as appropriate to levels of measurement for the variable, comparing
participants grouped by haplotype. Using independent samples t-test, participants were
grouped based on their status as patient or a caregiver to ascertain if there were
differences between the groups in salt taste sensitivity, fungiform papillae number, and
24-hour urinary sodium. Participants were grouped by haplotype as (PAV homozygous,
PAV/AVI, or AVI homozygous). To examine if PAV homozygous or PAV heterozygous
haplotype predicted salt taste sensitivity we conducted a linear regression with AVI
homozygous haplotype as the reference group. In the model, we controlled for age,
gender, non-Hispanic Caucasians referenced to participants from all other races, current
smoker referenced to nonsmokers, and fungiform papillae density. To determine whether
PAV homozygous or PAV heterozygous haplotype predicted baseline 24-hr urinary
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sodium excretion, we ran a linear regression with AVI homozygous haplotype as the
reference group controlling for age, gender, ethnicity, smoking status, and number of
fungiform papillae. All data analysis were conducted using SPSS v 24; with an a priori P
value of < 0.05.
Results
Three of the 46 participants were not included due to possessing a rare haplotype
and one was excluded for not having urine data resulting in a total of 42 participants
included in the analyses. The mean age of study participants was 64.6 + 13.4 years,
46.5% were male, and 97.7% were Caucasian. The majority (90.7%) were either nonsmokers or former smokers (Table 4.1). The mean of the salt taste sensitivity was 0.40 +
0.12; mean number of fungiform papillae was 63.1 + 18.3 and the mean 24-hour urinary
sodium was 4233.9 + 2046.8. There were no significant differences between patients and
caregivers for salt taste sensitivity (.42 + .13 vs .37 + 0.9; p = .16), fungiform papillae
number (62.5 + 19.5 vs. 63.7 + 17.5; p = .83), and 24-hour urinary sodium (4350.1 +
2161.1 vs. 3703.9 + 1868.9; p = .31). There were 10 PAV homozygotes, 19 PAV/AVI,
and 13 AVI homozygotes. More women than men were homozygous for the PAV
haplotype. There were no significant differences between those who were homozygous
PAV and those who were homozygous or heterozygous for the AVI haplotype.
Salt taste sensitivity. Neither PAV homozygous nor PAV/ AVI haplotype predicted
higher salt taste sensitivity in patients with HF or their family caregivers when compared
to the reference group, AVI homozygotes. No control variables predicted salt taste
sensitivity (Table 4.2).
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24-hour urinary sodium excretion. Participants who were PAV homozygous had
significantly lower levels of sodium in the 24-hour urinary excretion samples than those
who were AVI homozygous or PAV/AVI heterozygous. In the linear regression model,
PAV homozygosity predicted lower sodium excretion controlling for age, gender,
ethnicity, smoking history, and fungiform papillae density (b = -1780.59, t(41) = -2.18, p
= 0.036) (Table 4.3).
Discussion
Our hypothesis was partially upheld; although haplotype did not predict salt taste
sensitivity, being homozygous for the PAV haplotype predicted lower 24-hour urinary
sodium excretion, compared to AVI homozygotes. Lower 24-hour urinary sodium
excretion in patients with HF who are PAV homozygous may be due to lower
consumption of sodium. Earlier studies in which people who had greater intensity of
PROP bitterness during taste tests also had more intense salt taste (particularly in PAV
homozygotes) than those who didn’t detect PROP bitterness.29,142 They were also more
sensitive to changes in sodium concentration in food items.32 Lower 24-hour urinary
sodium excretion in PAV homozygotes in our study may be related to this increased
sensitivity. Although this was not supported by our salt sensitivity testing, it has been
shown in other studies including Hayes and colleagues who found that people who were
supertasters tended to notices changes in the concentration of sodium sooner and with
less sodium than those who were not supertasters.32 Moreover, people with the
supertasting phenotype were also more sensitive to changes in concentration of salt in
food items, which suggests a higher sensitivity to salt.32 Logically it would extend that
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those possessing the PAV haplotype who find the taste of salt more intense may also be
more sensitive to it in concentration, however our results did support this.
In this small pilot study, we did not find a difference in salt taste sensitivity
between PAV homozygotes and AVI homozygotes or between the AVI heterozygotes
and AVI homozygotes. This may be due to the method of testing we used, a stairstep updown trial that offered one solution at a time. It is possible that the test used to measure
salt taste sensitivity, which increased in 0.2% increments wasn’t sensitive enough to
detect the differences in salt taste sensitivity between haplotypes. In prior studies,
thresholds for salt taste sensitivity have been measured using a forced choice test where
the participant is offered two samples; one with salt solution and one with water, and are
asked to identify which one has the taste in it.143 This test also used 12 different
concentrations of salt solution instead of 8, as our test did.143 It might be more
informative to use a test with increases in concentration of salt in smaller increments than
0.2% as well as a forced choice option.
Another finding was that there was a significant gender difference in haplotype.
In our small sample, more females than males were homozygous or heterozygous for the
PAV haplotype. This finding has been noted before in a study that took place in a
genetically isolated population in Italy. In that sample there were more women who were
supertasters (PAV homozygotes) and more males who were nontasters (AVI
homozygotes).144 However, it is interesting given that in an earlier study with 42 women
and 45 men, Hayes and colleagues found , that women liked higher concentrations of salt
in chicken broth compared to men when tasting seven different sodium concentrations of
broth.32 Although the sample for our study was small and may not be representative of
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the population, our findings do support those of the two previous studies and suggest the
need to further explore genetic variations that may underlie sex-based taste differences.
Findings from this study should be interpreted with caution given the small
sample size of 42 people. Despite this, we did detect significant differences in 24-hour
urinary sodium excretion in PAV homozygotes compared to participants who were AVI
homozygotes. As previously discussed, our study was further limited in the test used for
salt taste sensitivity. Taste samples with increases in concentration much smaller than
0.2% coupled with forced choice may have been a more effective means of testing salt
taste sensitivity. Reflective of the Midwestern population served by clinics from which
we recruited for the parent study, the majority of our participants were of European
descent, limiting the generalizability of our findings to this population. While our
research was exploratory in nature, in light of our findings, replicating this study with a
larger sample drawn from a more diverse population is warranted.
Conclusions
In our sample of patients with HF and their family caregivers, being homozygous
for the PAV haplotype was the only significant predictor of 24-hour urinary sodium
excretion. This indicated that, compared to those who are homozygous AVI, persons with
the PAV/PAV genotype whereas there was not a significant difference from those who
were PAV/AVI. The findings in this small sample provide an exciting indication that
should be further explored in future research. Better understanding of genetic influences
on taste preferences and dietary choices are critical. This information can provide a basis
for the development of more effective personalized interventions for patients with HF.
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Table 4.1: Demographic Characteristics by TAS2R38 Haplotype
Mean (SD) or % (n)
Total Sample

PAV/PAV

PAV/AVI

AVI/AVI

P

Characteristic

N=42

n=10

n=19

n = 13

value

Age (years)

64.6 ± 13.4

60.1 ± 15.6

66.3 ± 10.5

67.5 + 14.8

.396

Gender (male)

46.5 % (20)

50.0% (5)

26.3% (5)

71.4% (10)

.019

Ethnicity

97.7 % (41)

90.0% (9)

100.0% (19)

100% (13)

.194

90.7 % (39)

90.0% (9)

100%% (19)

92.3% (12)

0.40 ± 0.12

0.38 ± 0.10

0.38 ± 0.10

0.42 ± 0.15

.606

63.1 ± 18.3

64.0 + 19.0

67.8 + 16.8

54.9 ± 19.1

.151

4234.0± 2046.8

3313.7 ± 1178.7

3723.9 ± 1399.8

5018.6 ± 2890.3

.088

(Caucasian)
.406

Smoking
status
(nonsmoker)
Salt taste
Sensitivity
Fungiform
papillae
density per
10mm
24 hour urine
sodium (mg)
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Table 4.2: Associations of TAS2R38 Haplotype and Salt Taste Sensitivity.
Variable

b

Standard error

β

P value

Age

-0.002

0.002

-0.275

.152

Gender

-0.052

0.042

-0.221

.228

Ethnicity

-0.139

0.140

-0.179

.326

Smoking history

0.054

0.070

0.135

.446

Fungiform papillae density

0.000

0.001

0.059

.725

PAV/AVI

-0.019

0.048

-0.079

.698

PAV homozygotes

-0.037

0.052

-0.135

.476

Haplotype [AVI homozygotes (ref)]

Model F = 0.937; R2= 0.158; P= 0.491
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Table 4.3: Predictors of 24-Hour Urinary Sodium Excretion
Variable

b

Standard error

β

P value

Age

-32.893

25.567

-0.214

.207

Gender

-1069.95

652.728

-0.267

.110

Ethnicity

-1883.915

2150.844

-0.144

.387

Smoking History

2335.645

1184.842

0.301

.057

29.325

16.907

0.268

.092

PAV/AVI

-1103.123

754.524

-0.275

.153

PAV homozygotes

-1780.593

815.531

-0.380

.036

Fungiform Papillae Density
Haplotype [AVI homozygotes (ref)]

Model F= 2.33; R2 = 0.32; P= 0.047
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CHAPTER FIVE:
Conclusions
Background and Purpose
The overall purpose of these studies was to examine key factors that influence
dietary intake patterns with a particular focus on sodium consumption. Understanding
taste perception and dietary consumption of sodium as well as other dietary components
among persons with CVD disease risk and those with HF is critical to developing
effective nutrition interventions. Those with CVD risk and with HF are particularly
vulnerable to experience negative health outcomes related to overconsumption of
sodium and can most benefit from reducing sodium consumption to 2,300 mg of sodium
per day or less.78 Three data-based manuscripts are included in this dissertation that focus
on taste perception and dietary consumption of sodium and other nutrients: 1) a
secondary analysis of data to examine the associations of prescribed anti-hypertensive
medication and sodium consumption in patients with HF, 2) a secondary analysis of data
to elucidate associations of TAS2R38 haplotype and dietary consumption of key nutrients
that effect cardiovascular health such as sodium, saturated fats, sugars, alcohol, and
vegetables, and 3) a cross sectional study to examine the association of TAS2R38
haplotype with salt taste sensitivity and 24-hour urinary sodium excretion.
The common element across each of these studies is a focus on dietary sodium
intake patterns. Although current dietary guidelines recommend consuming 2,300 mg of
sodium a day, nearly 90% of Americans consume 3,500 mg or more a day.1-5 Excess
sodium consumption has been linked with poor health outcomes including hypertension,
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high risk of stroke, and worsening heart failure.2,7,12 It is crucial to explore the issue of
excess sodium consumption to uncover new and innovative solutions to help people to
reduce their sodium consumption, particularly those who already have or are at high risk
of developing CVD. As taste strongly influences dietary choices, it is imperative to
examine associations of taste perception and underlying factors with dietary sodium
consumption.
The purpose of this chapter is to summarize and synthesize the findings of this
dissertation and to discuss the implications for advancing the state of the science on taste
perception and the consumption of dietary sodium and other nutrients.
Summary of findings
Chapter Two was a secondary analysis of data examining the relationship
between prescribed anti-hypertensive medication regimen and dietary sodium
consumption as evidenced by sodium density among patients with HF. Patients
prescribed ACE inhibitors consumed approximately 13% more sodium per kilocalorie
than those who were not prescribed ACE inhibitors. No other hypertensive medication,
including ARBs, beta blockers, and diuretics, predicted sodium density. Only being
prescribed an ACE inhibitor was significantly associated with higher sodium
consumption. Nurses could use this information to tailor education for patients on ACE
inhibitors to help them reduce their sodium intake with the knowledge that their
medication regimen may make it more difficult to adjust their diets.
Chapter Three was a secondary analysis of data examining the association
between TAS2R38 haplotype and dietary consumption of sodium, sugar, saturated fats,
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alcohol and vegetables in community dwelling adults with two or more CVD risk factors.
Findings of this study demonstrated that TAS2R38 haplotype was not associated with
dietary consumption of sodium, sugar, saturated fat, alcohol, and vegetables in this
population. While other variables in the model did predict dietary consumption of some
of these nutrients, genotype was not a significant predictor.
Chapter Four was a prospective, cross sectional study of the relationships among
TAS2R38 haplotype and salt taste sensitivity and sodium consumption as indicated by 24hour urinary sodium excretion. TAS2R38 genotype was not a significant predictor of salt
taste sensitivity, however, genotype was a significant predictor of 24-hour urinary sodium
excretion. Participants with the PAV homozygous haplotype had significantly lower
sodium excretion than those homozygous for the AVI haplotype. If supported by future
research, this information could be used by nurses and other health professionals to
develop tailored dietary interventions to lower sodium consumption based on genotype
and other factors that influence taste perception.
Impact of dissertation on the state of the science
There is little information regarding how factors related to salt taste perception are
associated with sodium consumption in patients with high CVD risk or who are currently
living with CVD. Although it is well known that taste is one of the most important factors
in food choice, there is little in the way of interventions that incorporate the importance
of the sense to improve dietary adherence to healthy dietary recommendations including
low sodium diet. This dissertation adds to the scientific literature in several important
ways. Our first study provides evidence that patients with HF who were prescribed ACE
inhibitors consume more sodium per kilocalorie than those who are not prescribed ACE
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inhibitors. In our second study, we did not find evidence that the TAS2R38 haplotype
predicted patterns of sodium, sugar, saturated fat, alcohol, and vegetable consumption in
community-dwelling adults with two or more CVD risk factors. Results from our third
study did not show TAS2R38 haplotype to be predictive of salt taste sensitivity but did
show that the haplotype predicted 24 hour urinary sodium excretion in patients with HF
and their family caregivers.
First, in Chapter Two, we explored the role of medication in adherence to low
sodium diet in patients with HF through the examination of prescribed medications and
dietary consumption of sodium. ACE inhibitors are frequently prescribed to patients with
HF as part of the medical management of the condition as stipulated by the guidelines put
forth by the American Heart Association and the American College of Cardiology.145 In
the same set of guidelines, it is also recommended that the reduction of dietary sodium145
which offers a unique contradiction to patients, particularly if the medication they take
indirectly influences them to eat more sodium in their diets. Understanding of the
challenges presented by taking an ACE inhibitor allows practitioners to plan for these
challenges and give precise educational instructions to better assist patients with HF in
meeting both treatment goals. This information furthers the knowledge that ACE
inhibitors disturb taste function by adding the information that those on these medications
consume more sodium, possibly because of taste disturbance. Education can be altered
pre-emptively to incorporate prescription of ACE inhibitors in order to prepare patients
for the possibility of taste disturbance and give them understanding of how this may
affect their attempts to lower sodium in their diets.
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In Chapter Three we explored the contributions of TAS2R38 genotype, which has
been known to alter dietary behavior through enhancement of the bitter modality of taste,
to dietary consumption of several nutrients that are known to be influential in cardiac
health and risk for CVD. The results of this study support reported outcomes from several
recent community-based studies in which no significant differences in dietary
consumption patterns have been found based on the PAV or AVI haplotype,111 it is
contrary to other studies that have shown haplotypic differences in both alcohol146 and
vegetable intake.27 While adding to the scientific debate regarding the influence of the
bitter-tasting genotype on consumption patterns for a sample of community dwelling
adults, the study also elucidated the need to control for certain variables and thus to refine
the design of our prospective study, presented in Chapter Four. In particular, phenotype
testing should be added along with the genotype testing approach as well as adding a
representation of fungiform papillae density to control for sensory equipment and
function. Furthermore, this study elucidated the role of TAS2R38 genotype in healthy
eating patterns in people with cardiovascular risk factors, which had not been
investigated before now, thus furthering the state of the science.
In Chapter Four, we report on a study conducted to examine the associations of
TAS2R38 genotype with salt taste sensitivity and 24-hour urinary sodium excretion in a
sample of patients with HF and their family caregivers. In a prior study, Hayes and
colleagues found that TAS2R38 phenotype was related to sodium taste ability and liking
of sodium in chicken broth and commonly consumed food items, though this study did
not test for phenotype.32 Our study filled the gap in the literature by directly examining
the association of TAS2R38 haplotype with both 24-hour urinary sodium excretion as a

62

proxy for sodium consumption and with salt taste sensitivity. The findings of this study
that the PAV homozygotes had significantly higher 24-hour urinary sodium excretion
than AVI homozygotes suggests that in patients with HF and their family members there
may be differences in sodium consumption based on the TAS2R38 haplotype. Although
contrary to the findings from our previous study with a community dwelling adult at-risk
for CVD, it may be that for people for whom LSD adherence is critical, genetic
influences on taste perception may have a stronger role in consumption patterns. This
pilot study provides direction to inform future research to enhance our understanding of
genetic influences on dietary patterns.
Recommendations for Nursing Practice and Research
Taking an ACE inhibitor is associated with greater dietary consumption of
sodium and it is thought to produce this effect through reduction of salt taste perception.
Because ACE inhibitors are frequently prescribed to HF patients who are also
recommended to follow a low sodium diet, it is imperative to consider medication
regimen when planning out educational interventions to assist these patients in adherence
to low sodium diet. Future research into this area should involve testing basic sensory
perception such as salt taste sensitivity in individuals taking an ACE inhibitor who also
have HF in order to elucidate how much salt taste perception is altered by the medication.
As it is suspected that ACE inhibitors cause taste disturbance through depletion of zinc,
we also recommend examining the addition of a zinc supplement to the medication
regimen for patients with HF who are also taking an ACE inhibitor to examine it’s
efficacy in relieving taste disturbance. Any future studies should also control for other
medications taken such as ARBs, diuretics, and beta blockers.
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It is perhaps surprising that in Chapter Three we found that this genotype did not
associate with consumption of sodium, sugar, saturated fat, alcohol, and vegetables in
community dwelling adults with two or more risk factors for CVD. However, the
literature is rife with contradictory reports of associations with this genotype and dietary
consumption patterns. Future community studies should be conducted that include testing
for the bitter taste phenotype of supertasting as well as the TAS2R38 haplotype, which
may give a more informative result. Such studies should be tightly controlled for factors
such as fungiform papillae number, salt taste sensitivity, and socioeconomic variables in
order to better account for possible confounders.
Conversely, as detailed in Chapter Four, TAS2R38 genotype did relate to 24 hour
urinary sodium excretion in a sample of patients with HF and their family caregivers.
Although our sample for this study was small, our findings can guide the efforts of future
research in the area of TAS2R38 haplotype and dietary food choices. Future research
should utilize a larger, more heterogenous sample to further examine the association of
PAV homozygosity and 24-hour urinary sodium excretion. Better understanding genetic
and other influences on dietary choices can support more effective dietary interventions
supportive of adherence to low sodium diet. Educational interventions can be tailored to
address variations in taste perceptions that may otherwise present a barrier to adherence
to low sodium diet.

64

Summary
Future research is needed to better elucidate the associations between TAS2R38 haplotype
and dietary consumption patterns as well as between haplotype and taste preferences.
Such studies conducted with heterogeneous samples and controlling for variables that
impact taste including fungiform papillae density and taste perception using high
sensitivity tests will be able to provide important insights into diet choices. As additional
genes that have a role in taste perception are discovered, subsequent research could also
expand the number of genetic variants examined to provide broader understanding of
genetic influences on taste and diet patterns and choices. This research can inform
development of tailored dietary interventions that may more effectively reduce CVD risk
among those at risk and improve health outcomes for those with CVD.
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